Table 3:
Relationship between duration of brain stem symptoms, coma duration, patient age, and posttreatment score
Posttreatment Scores |
n | |||
---|---|---|---|---|
mRS 0–2 (%) | mRS 3–4 (%) | mRS 5–6 (%) | ||
Duration of brain stem symptoms (P < .020*) | ||||
0–4 hours | 31 | 28 | 41 | 51 |
4.5–8 hours | 22 | 29 | 49 | 63 |
8.5–12 hours | 16 | 22 | 62 | 32 |
>12 hours | 11 | 33 | 56 | 18 |
Coma duration (P < .001*) | ||||
0.5–4 hours | 22 | 24 | 53 | 45 |
4.5–8 hours | 10 | 26 | 65 | 31 |
8.5–12 hours | 0 | 20 | 80 | 10 |
Patient’s age (P < .020) | ||||
22–39 years | 42 | 25 | 33 | 24 |
40–69 years | 22 | 31 | 47 | 118 |
>70 years | 15 | 21 | 65 | 34 |
Note:—*indicates univariable testing; mRS, modified Rankin scale.